Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
about
Sulfotransferase genetic variation: from cancer risk to treatment responsePotentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis.Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways.The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.Abnormalities of DNA repair mechanisms in common hematological malignancies.Vascular endothelial growth factor signaling in acute myeloid leukemia.Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity.DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype.Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.Pharmacogenomics and the treatment of acute myeloid leukemia.Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML.Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704.MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis.Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia.MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.
P2860
Q27027019-64998C6B-E1AE-4F9D-84E4-BD55416EAE52Q31170960-58034FC0-7C08-44C5-9F5F-9CE312DC905EQ33442358-20A63477-2480-43E0-9DDF-15900F6D3FF0Q34002516-74FDC346-715A-4A9A-85DF-6C4195AE83DBQ34052352-3452C986-472D-47C8-AD9C-A19F555EAF4AQ34401264-156D3E1E-BB11-44A2-8ACB-EE9A307EB33CQ34411659-EA4CF82B-78CD-48A1-B342-9522C4BD4809Q35091367-DF9CCF78-6770-46FF-BE60-ACF8A3C17B44Q35528622-DEC0BCF4-AFBE-4620-B24D-6741DB572458Q35753087-6CD3473D-BD04-493B-9802-0083139C906EQ37857869-A15BEDFB-11FE-43D0-A509-057959B910F1Q38029546-C0EB35EF-3576-4DCD-9018-ABE662560712Q38136704-B90DDE59-E604-4361-81D4-7E712CAA3A19Q38238954-7AE7D656-ACE5-4105-BEDB-F00AEFFC0CDEQ38445540-A766FBB3-3C0D-4A09-AA53-E80F7A006A66Q38694866-27EC5197-35D7-4E14-8B20-AAB423661550Q38887034-CBF4835A-90BD-422B-A0CF-5D32FBDE0497Q40969169-1D01932A-B971-40DA-A416-B7A7C6C4CDE5Q41383056-1C3D0F90-FCC5-4DA5-80A0-4DBE6DA9F5FAQ44546647-34347E76-E6CF-4ECB-82B7-5E3FB42CF1EBQ50874052-F114F5D2-7E06-4772-AD7D-EFCA1DF9270CQ54343007-0DC81210-21F0-4857-9811-AC56DD9E792AQ54426860-613CCE89-88C3-4469-AC80-C779A5532C74
P2860
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Genomic polymorphisms provide ...... k acute myeloblastic leukemia.
@ast
Genomic polymorphisms provide ...... k acute myeloblastic leukemia.
@en
type
label
Genomic polymorphisms provide ...... k acute myeloblastic leukemia.
@ast
Genomic polymorphisms provide ...... k acute myeloblastic leukemia.
@en
prefLabel
Genomic polymorphisms provide ...... k acute myeloblastic leukemia.
@ast
Genomic polymorphisms provide ...... k acute myeloblastic leukemia.
@en
P2093
P50
P1433
P1476
Genomic polymorphisms provide ...... sk acute myeloblastic leukemia
@en
P2093
Alvaro Urbano-Ispizua
Andreu Llorente
Emili Montserrat
Granada Perea
Javier Bueno
Jordi Esteve
Jordi Sierra
Josep M Ribera
Juan Berlanga
P304
P356
10.1182/BLOOD-2005-08-3272
P407
P577
2006-02-28T00:00:00Z